PortfoliosLab logoPortfoliosLab logo
GDOC vs. FTXH
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

GDOC vs. FTXH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Goldman Sachs Future Health Care Equity ETF (GDOC) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

GDOC vs. FTXH - Yearly Performance Comparison


2026 (YTD)20252024202320222021
GDOC
Goldman Sachs Future Health Care Equity ETF
-8.12%10.74%-1.66%4.60%-17.12%-2.77%
FTXH
First Trust Nasdaq Pharmaceuticals ETF
4.48%24.15%2.98%-1.41%2.55%0.10%

Returns By Period

In the year-to-date period, GDOC achieves a -8.12% return, which is significantly lower than FTXH's 4.48% return.


GDOC

1D
2.76%
1M
-5.94%
YTD
-8.12%
6M
2.88%
1Y
1.53%
3Y*
0.66%
5Y*
10Y*

FTXH

1D
2.61%
1M
-3.36%
YTD
4.48%
6M
21.14%
1Y
26.79%
3Y*
11.30%
5Y*
7.36%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


GDOC vs. FTXH - Expense Ratio Comparison

GDOC has a 0.75% expense ratio, which is higher than FTXH's 0.60% expense ratio.


Return for Risk

GDOC vs. FTXH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GDOC
GDOC Risk / Return Rank: 1414
Overall Rank
GDOC Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
GDOC Sortino Ratio Rank: 1313
Sortino Ratio Rank
GDOC Omega Ratio Rank: 1313
Omega Ratio Rank
GDOC Calmar Ratio Rank: 1414
Calmar Ratio Rank
GDOC Martin Ratio Rank: 1414
Martin Ratio Rank

FTXH
FTXH Risk / Return Rank: 6868
Overall Rank
FTXH Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
FTXH Sortino Ratio Rank: 7171
Sortino Ratio Rank
FTXH Omega Ratio Rank: 6565
Omega Ratio Rank
FTXH Calmar Ratio Rank: 7575
Calmar Ratio Rank
FTXH Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GDOC vs. FTXH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Goldman Sachs Future Health Care Equity ETF (GDOC) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GDOCFTXHDifference

Sharpe ratio

Return per unit of total volatility

0.08

1.28

-1.19

Sortino ratio

Return per unit of downside risk

0.25

1.78

-1.53

Omega ratio

Gain probability vs. loss probability

1.03

1.24

-0.21

Calmar ratio

Return relative to maximum drawdown

0.10

1.95

-1.85

Martin ratio

Return relative to average drawdown

0.31

5.94

-5.63

GDOC vs. FTXH - Sharpe Ratio Comparison

The current GDOC Sharpe Ratio is 0.08, which is lower than the FTXH Sharpe Ratio of 1.28. The chart below compares the historical Sharpe Ratios of GDOC and FTXH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


GDOCFTXHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.08

1.28

-1.19

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.46

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.20

0.38

-0.58

Correlation

The correlation between GDOC and FTXH is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Dividends

GDOC vs. FTXH - Dividend Comparison

GDOC's dividend yield for the trailing twelve months is around 0.35%, less than FTXH's 1.23% yield.


TTM2025202420232022202120202019201820172016
GDOC
Goldman Sachs Future Health Care Equity ETF
0.35%0.32%0.02%0.55%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FTXH
First Trust Nasdaq Pharmaceuticals ETF
1.23%1.41%1.66%1.55%1.11%1.03%0.82%0.67%0.91%2.18%0.19%

Drawdowns

GDOC vs. FTXH - Drawdown Comparison

The maximum GDOC drawdown since its inception was -31.01%, roughly equal to the maximum FTXH drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for GDOC and FTXH.


Loading graphics...

Drawdown Indicators


GDOCFTXHDifference

Max Drawdown

Largest peak-to-trough decline

-31.01%

-32.11%

+1.10%

Max Drawdown (1Y)

Largest decline over 1 year

-14.57%

-12.74%

-1.83%

Max Drawdown (5Y)

Largest decline over 5 years

-19.51%

Current Drawdown

Current decline from peak

-15.86%

-3.36%

-12.50%

Average Drawdown

Average peak-to-trough decline

-15.90%

-5.88%

-10.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.96%

4.68%

+0.28%

Volatility

GDOC vs. FTXH - Volatility Comparison

Goldman Sachs Future Health Care Equity ETF (GDOC) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) have volatilities of 6.04% and 6.24%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


GDOCFTXHDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.04%

6.24%

-0.20%

Volatility (6M)

Calculated over the trailing 6-month period

11.22%

12.06%

-0.84%

Volatility (1Y)

Calculated over the trailing 1-year period

18.63%

21.10%

-2.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.83%

16.15%

+2.68%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.83%

18.45%

+0.38%